Charles S. Ryan - Net Worth and Insider Trading

Charles S. Ryan Net Worth

The estimated net worth of Charles S. Ryan is at least $5 dollars as of 2024-04-28. Charles S. Ryan is the Director of BioRestorative Therapies Inc and owns about 4 shares of BioRestorative Therapies Inc (BRTX) stock worth over $5. Details can be seen in Charles S. Ryan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charles S. Ryan has not made any transactions after 2015-12-07 and currently still holds the listed stock(s).

Transaction Summary of Charles S. Ryan

Charles S. Ryan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Charles S. Ryan owns 4 companies in total, including Neurotrope Inc (NTRP) , Applied DNA Sciences Inc (APDN) , and BioRestorative Therapies Inc (BRTX) among others .

Click here to see the complete history of Charles S. Ryan’s form 4 insider trades.

Insider Ownership Summary of Charles S. Ryan

Ticker	Comapny	Transaction Date	Type of Owner
NTRP	Neurotrope Inc	2019-12-13	director & Chief Executive Officer
APDN	Applied DNA Sciences Inc	2018-03-15	director
BRTX	BioRestorative Therapies Inc	2015-12-07	director
QNCX	Quince Therapeutics Inc	2023-09-01	President

Charles S. Ryan Latest Holdings Summary

Charles S. Ryan currently owns a total of 1 stock. Charles S. Ryan owns 4 shares of BioRestorative Therapies Inc (BRTX) as of December 7, 2015, with a value of $5.

Latest Holdings of Charles S. Ryan

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
BRTX	BioRestorative Therapies Inc	2015-12-07	4	1.25	5

Holding Weightings of Charles S. Ryan

Charles S. Ryan Form 4 Trading Tracker

According to the SEC Form 4 filings, Charles S. Ryan has made a total of 0 transactions in BioRestorative Therapies Inc (BRTX) over the past 5 years. The most-recent trade in BioRestorative Therapies Inc is the acquisition of 2 shares on December 7, 2015, which cost Charles S. Ryan around $25,000.

Insider Trading History of Charles S. Ryan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Charles S. Ryan Trading Performance

GuruFocus tracks the stock performance after each of Charles S. Ryan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles S. Ryan is 8.22%. GuruFocus also compares Charles S. Ryan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles S. Ryan within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Charles S. Ryan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Charles S. Ryan

Average Return

-40.91%

Average return per transaction

Outperforming Transactions

0%

0 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-5.7	8.22	-31.78	-40.91	-22.18	-38.29
Relative Return to S&P 500(%)	-1.6	10.95	-32.22	-43.46	-31.75	-46.44

Charles S. Ryan Ownership Network

Ownership Network List of Charles S. Ryan

No Data

Ownership Network Relation of Charles S. Ryan

Charles S. Ryan Owned Company Details

What does Neurotrope Inc do?

Who are the key executives at Neurotrope Inc?

Charles S. Ryan is the director & Chief Executive Officer of Neurotrope Inc. Other key executives at Neurotrope Inc include COO and General Counsel Michael Ciraolo , See Remarks Robert Weinstein , and See Remarks Daniel L. Alkon .

Neurotrope Inc (NTRP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Neurotrope Inc (NTRP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neurotrope Inc (NTRP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neurotrope Inc (NTRP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neurotrope Inc Insider Transactions

No Available Data

What does Applied DNA Sciences Inc do?

Who are the key executives at Applied DNA Sciences Inc?

Charles S. Ryan is the director of Applied DNA Sciences Inc. Other key executives at Applied DNA Sciences Inc include Chief Legal Officer Clay Shorrock , 10 percent owner William W Montgomery , and Chief Information Officer Judith Murrah .

Applied DNA Sciences Inc (APDN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Applied DNA Sciences Inc (APDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Applied DNA Sciences Inc (APDN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Applied DNA Sciences Inc (APDN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Applied DNA Sciences Inc Insider Transactions

No Available Data

What does BioRestorative Therapies Inc do?

Who are the key executives at BioRestorative Therapies Inc?

Charles S. Ryan is the director of BioRestorative Therapies Inc. Other key executives at BioRestorative Therapies Inc include director & 10 percent owner & VP of Research and Development Francisco Silva , 10 percent owner Dale Broadrick , and director & 10 percent owner & President & CEO & COB Lance Alstodt .

BioRestorative Therapies Inc (BRTX) Insider Trades Summary

Over the past 18 months, Charles S. Ryan made no insider transaction in BioRestorative Therapies Inc (BRTX). Other recent insider transactions involving BioRestorative Therapies Inc (BRTX) include a net purchase of 14,087 shares made by Lance Alstodt , a net purchase of 302,972 shares made by Dale Broadrick , and a net purchase of 14,952 shares made by Francisco Silva .

In summary, during the past 3 months, insiders sold 0 shares of BioRestorative Therapies Inc (BRTX) in total and bought 288,308 shares, with a net purchase of 288,308 shares. During the past 18 months, 528 shares of BioRestorative Therapies Inc (BRTX) were sold and 332,539 shares were bought by its insiders, resulting in a net purchase of 332,011 shares.

BioRestorative Therapies Inc (BRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

BioRestorative Therapies Inc Insider Transactions

No Available Data

What does Quince Therapeutics Inc do?

Who are the key executives at Quince Therapeutics Inc?

Charles S. Ryan is the President of Quince Therapeutics Inc. Other key executives at Quince Therapeutics Inc include Chief Scientific Officer Guenter Janhofer , director & Chief Executive Officer Dirk Thye , and Chief Business Officer Brendan Hannah .

Quince Therapeutics Inc (QNCX) Insider Trades Summary

Over the past 18 months, Charles S. Ryan made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 168,000 shares made by Dirk Thye , and a net purchase of 71,762 shares made by Brendan Hannah .

In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,871 shares of Quince Therapeutics Inc (QNCX) were sold and 748,198 shares were bought by its insiders, resulting in a net purchase of 746,327 shares.

Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Quince Therapeutics Inc Insider Transactions

No Available Data

Charles S. Ryan Mailing Address

Above is the net worth, insider trading, and ownership report for Charles S. Ryan. You might contact Charles S. Ryan via mailing address: C/o Applied Dna Sciences, Inc., 50 Health Sciences Drive, Stony Brook Ny 11790.

Discussions on Charles S. Ryan

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.